This blog is focused on providing people who have been diagnosed with either a rare cancer or with more than one cancer a place where they can keep up with information, research and discoveries that could impact their lives in the near term.

Rare cancers and multiple cancers have been ignored for too long. Research dollars are far too limited.

Please let us know if you hear of anything new that needs to be shared with our community.

Rare Cancers

Cancer ABCs

October 3, 2018

Rare Cancers, Treatment Side Effects, von Hippel-Lindau Disease

Pazopanib Shows Promise in von Hippel-Lindau Disease - A Rare Cancer Syndrome

Cancer ABCs

October 3, 2018

Rare Cancers, Treatment Side Effects, von Hippel-Lindau Disease

Results from the first prospective trial of systemic treatment for von Hippel-Lindau (VHL) disease show that the antiangiogenic agent pazopanib (Votrient, Novartis) could offer a "realistic option" to surgical resection in patients with this rare, inherited cancer syndrome.

To subscribe to the Cancer ABCs Rare and Multiple Cancer Blog please fill out the form below. You can unsubscribe at any time.

Name

First Name

Last Name

Email Address

Subscribe/Unsubscribe

Unsubscribe

Are you a human or a robot? When subscribing to the Rare & Multiple Cancer Blog help us avoid spam by adding the word EARTH in the box below